LAS VEGAS, NV--(Marketwired - Apr 15, 2014) - Earth Science Tech, Inc. (OTCQB: UNOV) ("EST" or "the Company"), a specialty biotechnology company focused on nutraceuticals and bioceuticals, announces the appointment of Dr. Harvey Katz as CEO effective today. Dr. Issa El-Cheikh has stepped down as the CEO and is now the CFO. Dr. Katz is a seasonal professional with an extensive background in science, chemistry, engineering and the public arena. EST and its shareholders will be well represented by Dr. Katz at the helm and will look to benefit from his extensive experience in moving the company forward.
"Our first goal is to help and improve the quality of life for millions of individuals. Our second goal is to have the highest quality control possible, including reliable information not only on our label but on all-collateral material as well. By following these creeds we'll give our shareholders and customers a quality company far beyond what is currently the norm therefore helping the company develop a strong consumer base. EST is going to bring additional products to the market place in a very short time. We will only do this after our products are safe, effective and have independent labs approve the test results. By doing this we help safeguard and protect the consumer and our shareholders."
Dr. Katz went on to say, "I'm very excited about heading up EST with the other members of the organization. I was so impressed with the future of the company and its present management that when asked about compensation I said I will not take any cash compensation for six months to show the current shareholders my commitment to the company. I want to assure the shareholders that EST will have an open line of communication. I plan to use press releases to communicate with ALL shareholders and to keep them abreast of new developments within the company. Please remember there are some items that cannot be released until all approvals and criteria's are met."
Dr. Katz was educated at Loop City College, Loyola University, the University of Chicago, all in Chicago, Illinois and Stafford University .He majored in Business and Environmental Science. Dr. Katz has had articles published and lectured at the University of Florida Department Of Plastics, University of Nevada Las Vegas, Virginia Tech and others. Currently he is affiliated with the University of Texas-Center for ElectroMechanics. He was the Honorary Chairman of the Republican Committee in Florida while President Bush (43) was in office. He was asked and accepted an appointment to an economic committee and was honored with a presidential medal for his contributions to the party and country.
Dr. Katz is currently representing Earth Science Tech as a member of the "International Cannabinoid Research Society (ICRS)," he's a member of Congressional Research Service, Society of Petroleum Engineers, American Chemical Society, and has been a member of other nonprofessional organizations such as Society of Military Engineers, Who's Who in America.
ABOUT: Earth Science Tech, Inc. (EST) is a unique biotechnology company focused on cutting edge nutraceuticals and bioceuticals. The company provides seamless science-based solutions designed to excel in industries such as health, wellness, nutrition, supplement, cosmetic and alternative medicine to improve the quality of life for consumers worldwide. EST is dedicated in providing all natural alternatives to prescription medications that help improve common disorders and illnesses. EST is focused on delivering nutritional and dietary supplements that help with treating symptoms such as: chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea, aging and overall wellness. This may include products such as vitamins, minerals, herbs, botanicals, personal care products, homeopathics, functional foods, and other products. These products will be in various formulations and delivery forms including capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.